Role of Glucocorticoids in Breast Cancer

被引：0
作者：
Vaidya, Jayant S. [1 ]
Baldassarre, Gustavo
Thorat, Mangesh A. [3 ]
Massarut, Samuele [2 ]
机构：
[1] UCL, Div Surg & Intervent Sci, Dept Surg Res, London N19 5LW, England
[2] Natl Canc Inst, Ctr Riferimento Oncol, Breast Surg Unit, Aviano, Italy
[3] Univ London, Barts & London Sch Med & Dent Queen Mary, Wolfson Inst Prevent Med, CRUK Ctr Epidemiol Math & Stat, London WC1E 7HU, England
来源：
CURRENT PHARMACEUTICAL DESIGN | 2010年 / 16卷 / 32期
关键词：
Glucocorticoids; steroids; breast cancer; review; circadian; paracrine; glucocorticoid receptor; treatment; TARGETED INTRAOPERATIVE RADIOTHERAPY; RADIATION-INDUCED APOPTOSIS; PRIMARY ENDOCRINE TREATMENT; STEROID-HORMONE RECEPTORS; CERVICAL-CARCINOMA CELLS; MAMMARY EPITHELIAL-CELLS; ONCOLOGY-GROUP TRIAL; FACTOR-KAPPA-B; ESTROGEN-RECEPTOR; MEDROXYPROGESTERONE ACETATE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Glucocorticoids play an essential role in embryonic development and tissue homeostasis and possess important anti-inflammatory and immunosuppressive properties. Due to their very wide spectrum of activity, glucocorticoids are one of the most commonly used drugs-used in the treatment of asthma, arthritis, autoimmune diseases and shock/SIRS. Glucocorticoids are a main component of treatment regimens in hematological malignancies due to their pro-apoptotic properties and are also used as co-treatment several other cancers and chemotherapy regimens including those in breast cancer treatment. In breast cancer, however, glucocorticoids may have diverse effects and could inhibit chemosensitivity. Additionally, glucocorticoids through their receptor may interact with ER in a feedback loop regulating each other's activities. The normal variation of glucocorticoid levels with time of the day, menstrual cycle or year could have a interesting chronobiological interaction with the well recorded variation in breast cancer proliferation and metastatic potential. Glucocorticoids could play a very complex role in breast cancer epidemiology, biology and treatment; this review aims to present a comprehensive discussion as well as speculate future directions for research.
引用
收藏
页码：3593 / 3600
页数：8
相关论文
共 123 条
[101]  
TORMEY DC, 1990, CANCER-AM CANCER SOC, V65, P200, DOI 10.1002/1097-0142(19900115)65:2<200::AID-CNCR2820650203>3.0.CO
[102]  
2-Q
[103]   LONG-TERM RESULTS OF TARGETED INTRAOPERATIVE RADIOTHERAPY (TARGIT) BOOST DURING BREAST-CONSERVING SURGERY [J].
Vaidya, Jayant S. ;
Baum, Michael ;
Tobias, Jeffrey S. ;
Wenz, Frederik ;
Massarut, Samuele ;
Keshtgar, Mohammed ;
Hilaris, Basil ;
Saunders, Christobel ;
Williams, Norman R. ;
Brew-Graves, Chris ;
Corica, Tammy ;
Roncadin, Mario ;
Kraus-Tiefenbacher, Uta ;
Suetterlin, Marc ;
Bulsara, Max ;
Joseph, David .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04) :1091-1097
[104]   Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial [J].
Vaidya, Jayant S. ;
Joseph, David J. ;
Tobias, Jeffrey S. ;
Bulsara, Max ;
Wenz, Frederik ;
Saunders, Christobel ;
Alvarado, Michael ;
Flyger, Henrik L. ;
Massarut, Samuele ;
Eiermann, Wolfgang ;
Keshtgar, Mohammed ;
Dewar, John ;
Kraus-Tiefenbacher, Uta ;
Suetterlin, Marc ;
Esserman, Laura ;
Holtveg, Helle M. R. ;
Roncadin, Mario ;
Pigorsch, Steffi ;
Metaxas, Marinos ;
Falzon, Mary ;
Matthews, April ;
Corica, Tammy ;
Williams, Norman R. ;
Baum, Michael .
LANCET, 2010, 376 (9735) :91-102
[105]   The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer [J].
Vaidya, JS ;
Baum, M ;
Tobias, JS ;
Morgan, S ;
D'Souza, D .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (04) :447-454
[106]   Targeted intra-operative radiotherapy (Targit):: An innovative method of treatment for early breast cancer [J].
Vaidya, JS ;
Baum, M ;
Tobias, JS ;
D'Souza, DP ;
Naidu, SV ;
Morgan, S ;
Metaxas, M ;
Harte, KJ ;
Sliski, AP ;
Thomson, E .
ANNALS OF ONCOLOGY, 2001, 12 (08) :1075-1080
[107]  
VAIDYA JS, 2002, THESIS U LONDON
[108]   Glucocorticoid receptor gene and risk of cardiovascular disease [J].
van den Akker, Erica L. T. ;
Koper, Jan W. ;
van Rossum, Elisabeth F. C. ;
Dekker, Marieke J. H. ;
Russcher, Henk ;
de Jong, Frank H. ;
Uitterlinden, Andre G. ;
Hofman, Albert ;
Pols, Huibert A. ;
Witteman, Jacqueline C. M. ;
Lamberts, Steven W. J. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) :33-39
[109]   Genetic polymorphisms and multifactorial diseases: facts and fallacies revealed by the glucocorticoid receptor gene [J].
van Rossum, EFC ;
Russcher, L ;
Lamberts, SWJ .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (10) :445-450
[110]   AMINOGLUTETHIMIDE PLUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS AMINOGLUTETHIMIDE PLUS CORTISONE IN THE TREATMENT OF METASTASIZING BREAST-CANCER - AN AIO PHASE-III STUDY [J].
WANDER, HE ;
BLOSSEY, HC ;
NAGEL, GA ;
KLEEBERG, UR ;
ESSERS, U .
ONKOLOGIE, 1987, 10 (05) :321-323
45678910111213